Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research report report published on Saturday. The brokerage issued a hold rating on the stock.

Retractable Technologies Price Performance

Shares of NYSE:RVP opened at $0.93 on Friday. The company has a 50 day moving average of $1.08 and a 200-day moving average of $1.11. Retractable Technologies has a twelve month low of $0.87 and a twelve month high of $1.34. The company has a quick ratio of 6.54, a current ratio of 9.51 and a debt-to-equity ratio of 0.01.

Retractable Technologies (NYSE:RVP) last released its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%. The firm had revenue of $6.03 million for the quarter.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.